Velan Capital Investment Management Lp Top Holdings and 13F Report (2026)

About Velan Capital Investment Management Lp

Investment Activity

Velan Capital Investment Management Lp has $164.21 million in total holdings as of June 30, 2026.
Velan Capital Investment Management Lp owns shares of 50 different stocks, but just 12 companies or ETFs make up 80% of its holdings.
Approximately 8.79% of the portfolio was purchased this quarter.
About 11.16% of the portfolio was sold this quarter.
This quarter, Velan Capital Investment Management Lp has purchased 49 new stocks and bought additional shares in 11 stocks.
Velan Capital Investment Management Lp sold shares of 10 stocks and completely divested from 5 stocks this quarter.

Largest Holdings

PRAXIS PRECISION MEDICINES I: $29,722,991
MAPLIGHT THERAPEUTICS INC: $17,665,285
SUTRO BIOPHARMA INC: $17,003,712
Immix Biopharma: $11,186,350
Protara Therapeutics: $10,866,571

Largest New Holdings this Quarter

12529R107 - C4 Therapeutics: $2,661,900 Holding
000899104 - ADMA Biologics: $2,092,500 Holding
00887A204 - REIN THERAPEUTICS INC: $1,768,000 Holding
878972108 - TECTONIC THERAPEUTIC INC: $206,250 Holding
037326105 - AN2 THERAPEUTICS INC: $193,600 Holding

Largest Purchases this Quarter

Immix Biopharma: 345,000 shares (about $3.56M)
C4 Therapeutics: 570,000 shares (about $2.66M)
AVALO THERAPEUTICS INC: 139,330 shares (about $2.57M)
ADMA Biologics: 250,000 shares (about $2.09M)
REIN THERAPEUTICS INC: 1,700,000 shares (about $1.77M)

Largest Sales this Quarter

PRAXIS PRECISION MEDICINES I: 12,000 shares (about $4.02M)
CytomX Therapeutics: 420,000 shares (about $1.58M)
ABIVAX SA: 11,370 shares (about $1.52M)
Viridian Therapeutics: 81,123 shares (about $1.49M)
InspireMD: 1,951,514 shares (about $1.37M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
PRAXIS PRECISION MEDICINES I	$29,722,991	$4,017,480 â–¼	-11.9%	88,781	18.1%	COM NEW
MAPLIGHT THERAPEUTICS INC	$17,665,285		0.0%	492,893	10.8%	COM
SUTRO BIOPHARMA INC	$17,003,712		0.0%	512,160	10.4%	COM SHS
IMMX Immix Biopharma	$11,186,350	$3,556,950 â–²	46.6%	1,085,000	6.8%	Healthcare
TARA Protara Therapeutics	$10,866,571	$38,200 â–²	0.4%	2,844,652	6.6%	Healthcare
TENAX THERAPEUTICS INC	$9,001,867	$514,372 â–²	6.1%	618,685	5.5%	COM NEW
ABIVAX SA	$8,745,854	$1,515,166 â–¼	-14.8%	65,630	5.3%	SPONSORED ADS
ANTERIS TECHNOLOGIES GLOBAL	$6,895,000		0.0%	700,000	4.2%	COM
EDESA BIOTECH INC	$6,727,575		0.0%	827,500	4.1%	COM NEW
EVOMMUNE INC	$5,997,179	$66,450 â–²	1.1%	451,255	3.7%	COM SHS
AVALO THERAPEUTICS INC	$5,995,873	$2,574,818 â–²	75.3%	324,452	3.7%	COM NEW
XNCR Xencor	$4,105,500	$80,500 â–²	2.0%	255,000	2.5%	Healthcare
RZLT Rezolute	$3,900,000		0.0%	750,000	2.4%	Healthcare
HRTX Heron Therapeutics	$3,735,904		0.0%	8,753,290	2.3%	Healthcare
VERRICA PHARMACEUTICALS INC	$2,885,941		0.0%	471,559	1.8%	COM SHS
CCCC C4 Therapeutics	$2,661,900	$2,661,900 â–²	New Holding	570,000	1.6%	Healthcare
EUPRAXIA PHARMACEUTICALS INC	$2,326,720		0.0%	352,000	1.4%	COM
ADMA ADMA Biologics	$2,092,500	$2,092,500 â–²	New Holding	250,000	1.3%	Healthcare
REIN THERAPEUTICS INC	$1,768,000	$1,768,000 â–²	New Holding	1,700,000	1.1%	COM NEW
LYELL IMMUNOPHARMA INC	$1,475,250	$42,150 â–²	2.9%	105,000	0.9%	COM NEW
NASUS PHARMA LTD	$1,257,865		0.0%	359,390	0.8%	ORD SHS
PROF Profound Medical	$1,132,349	$767,623 â–¼	-40.4%	170,278	0.7%	Healthcare
JASPER THERAPEUTICS INC	$1,123,394		0.0%	2,668,395	0.7%	COM NEW
PTGX Protagonist Therapeutics	$453,546		0.0%	3,700	0.3%	Healthcare
CTMX CytomX Therapeutics	$450,000	$1,575,000 â–¼	-77.8%	120,000	0.3%	Healthcare
NEUMORA THERAPEUTICS INC.	$391,000	$255,000 â–²	187.5%	230,000	0.2%	COM
NRIX Nurix Therapeutics	$388,160		0.0%	16,000	0.2%	Healthcare
OVID Ovid Therapeutics	$349,700	$80,700 â–¼	-18.8%	130,000	0.2%	Healthcare
PRECISION BIOSCIENCES INC	$314,400		0.0%	40,000	0.2%	COM NEW
MLYS Mineralys Therapeutics	$296,780		0.0%	11,000	0.2%	Healthcare
MGNX MacroGenics	$277,200	$138,600 â–²	100.0%	60,000	0.2%	Healthcare
CRBP Corbus Pharmaceuticals	$243,880		0.0%	26,000	0.1%	Healthcare
ARTIVA BIOTHERAPEUTICS INC	$242,500		0.0%	25,000	0.1%	COM
REPL Replimune Group	$221,400		0.0%	20,000	0.1%	Healthcare
SNDX Syndax Pharmaceuticals	$218,600		0.0%	10,000	0.1%	Healthcare
IMNM Immunome	$211,900		0.0%	10,000	0.1%	Healthcare
TECTONIC THERAPEUTIC INC	$206,250	$206,250 â–²	New Holding	6,000	0.1%	COM
RCKT Rocket Pharmaceuticals	$205,200	$802,479 â–¼	-79.6%	60,000	0.1%	Healthcare
KARYOPHARM THERAPEUTICS INC	$195,400	$48,850 â–²	33.3%	20,000	0.1%	COM NEW
AN2 THERAPEUTICS INC	$193,600	$193,600 â–²	New Holding	40,000	0.1%	COM
VRDN Viridian Therapeutics	$183,700	$1,490,230 â–¼	-89.0%	10,000	0.1%	Healthcare
SCYNEXIS INC	$162,800	$162,800 â–²	New Holding	40,000	0.1%	COM
QUOIN PHARMACEUTICALS LTD	$156,680	$253,988 â–¼	-61.8%	32,372	0.1%	SPONSORED ADS
XILIO THERAPEUTICS INC	$136,850		0.0%	14,285	0.1%	COM
NSPR InspireMD	$103,711	$1,366,250 â–¼	-92.9%	148,138	0.1%	Healthcare
KALARIS THERAPEUTICS INC	$101,750	$28,490 â–²	38.9%	25,000	0.1%	COM
LRMR Larimar Therapeutics	$100,650		0.0%	33,000	0.1%	Healthcare
PRQR ProQR Therapeutics	$83,700		0.0%	45,000	0.1%	Healthcare
CNTX Context Therapeutics	$33,068	$22,322 â–¼	-40.3%	59,700	0.0%	Healthcare
GOSS Gossamer Bio	$11,522		0.0%	70,000	0.0%	Healthcare
ESPR Esperion Therapeutics	$0	$4,712,800 â–¼	-100.0%	0	0.0%	Healthcare
KAZIA THERAPEUTICS LTD	$0	$1,006,744 â–¼	-100.0%	0	0.0%	SPONSORED ADS
ARWR Arrowhead Pharmaceuticals	$0	$407,550 â–¼	-100.0%	0	0.0%	Healthcare
DSGN Design Therapeutics	$0	$212,800 â–¼	-100.0%	0	0.0%	Healthcare
PMVP PMV Pharmaceuticals	$0	$90,520 â–¼	-100.0%	0	0.0%	Healthcare

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Velan Capital Investment Management Lp Top Holdings and 13F Report (2026)

About Velan Capital Investment Management Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Velan Capital Investment Management Lp Top Holdings and 13F Report (2026)

About Velan Capital Investment Management Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofVelan Capital Investment Management Lp

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools